MEDINDIA
English
हिन्दी
Español
français
中文
Biocon and its Israeli partner Quark Pharmaceuticals to proceed with human clinical trials for a new drug candidate, ‘QPI-1007’ targeting orphan eye disease.
Common Eye Disease Due to Outdoor Activities Prevented With Sunglasses
Exfoliation syndrome is an eye condition that is a leading cause of secondary open-angle glaucoma that can lead to an increased risk of cataract and cataract surgery complications.
Exfoliation syndrome is an eye condition that is a leading cause of secondary open-angle glaucoma that can lead to an increased risk of cataract and cataract surgery complications.
TOP INSIGHT
India's first siRNA therapy will benefit thousands of patients with acute non-arteritic ischemic optic neuropathy who either have no access to treatment or cannot afford it.
Both the companies have also received approval to proceed with the study, the first ever clinical trial of a siRNA (small interfering RNA) therapy in India.
Biocon CMD Kiran Mazumdar-Shaw said, “India has a significant NAION patient population. We are the first biopharma company in the country to provide an siRNA-based therapy that is likely to benefit thousands of patients who either have no access to treatment or cannot afford it.”
Device That can Detect Eye Disease by Simply Scanning the Retina Developed
A team of international scientists has developed a new hand-held optical device that simply scans the retina to detect whether a person is suffering from eye diseases.
A team of international scientists has developed a new hand-held optical device that simply scans the retina to detect whether a person is suffering from eye diseases.
Source-Medindia
Cheaper Alternative of Ranibizumab for Treating Eye Disease Has Similar Side-Effects
Health policies which favour using ranibizumab for treating eye disease in old people over safety concerns for a cheaper alternative should take account of a new Cochrane Review.
Health policies which favour using ranibizumab for treating eye disease in old people over safety concerns for a cheaper alternative should take account of a new Cochrane Review.
6.5pct of Americans Aged 40 and Above Have Eye Disease Macular Degenration
An estimated 6.5 percent of Americans age 40 and older have the eye disease age-related macular degeneration, a lower rate than was reported 15 years ago, according to a report in
An estimated 6.5 percent of Americans age 40 and older have the eye disease age-related macular degeneration, a lower rate than was reported 15 years ago, according to a report in
Email
